Benefits of FibroScan® to patients
Professor Graham Foster
BA FRCP PhD
What is FibroScan®?
FibroScan® is a simple, non-invasive
test performed in the outpatient clinic
that assesses liver fibrosis by revealing
the Liver Stiffness Measurement (LSM),
as assessed by an ultrasound-based
probe. It is recommended by NICE as the
most cost-effective, non-invasive test to
predict liver fibrosis, irrespective of the
underlying cause of the liver disease.
To assess liver fibrosis stage, FibroScan®
should be performed in people suspected
of having liver disease due to any of the
• Obesity or diabetes-related liver disease known
as Non-Alcoholic Fatty Liver Disease (NAFLD)
• Alcohol-related liver disease
• Hepatitis C or Hepatitis B virus
• Other types of chronic liver disease, such as
autoimmune hepatitis, primary biliary cholangitis,
haemochromatosis or unexplained persistently
raised liver test results.